Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ADVM |
---|---|---|
09:32 ET | 886 | 6.98 |
09:36 ET | 100 | 6.9 |
09:38 ET | 100 | 6.88 |
09:41 ET | 200 | 6.825 |
09:43 ET | 199 | 6.94 |
09:48 ET | 1698 | 6.98 |
09:50 ET | 1058 | 6.96 |
09:52 ET | 100 | 6.983 |
09:54 ET | 2398 | 6.94 |
09:56 ET | 300 | 6.945 |
09:57 ET | 887 | 6.96 |
10:01 ET | 100 | 6.975 |
10:03 ET | 1529 | 6.915 |
10:06 ET | 354 | 6.915 |
10:08 ET | 100 | 6.9 |
10:10 ET | 1000 | 6.89 |
10:12 ET | 300 | 6.85 |
10:17 ET | 100 | 6.8 |
10:24 ET | 317 | 6.82 |
10:26 ET | 100 | 6.81 |
10:28 ET | 242 | 6.82 |
10:32 ET | 500 | 6.795 |
10:33 ET | 246 | 6.78 |
10:35 ET | 2000 | 6.85 |
10:37 ET | 200 | 6.835 |
10:39 ET | 400 | 6.85 |
10:42 ET | 100 | 6.855 |
10:44 ET | 100 | 6.86 |
10:46 ET | 200 | 6.82 |
10:48 ET | 812 | 6.79 |
10:50 ET | 303 | 6.75 |
10:51 ET | 447 | 6.785 |
10:53 ET | 100 | 6.785 |
10:57 ET | 837 | 6.8 |
11:02 ET | 100 | 6.87 |
11:06 ET | 200 | 6.855 |
11:08 ET | 826 | 6.86 |
11:09 ET | 2103 | 6.83 |
11:11 ET | 21167 | 6.83 |
11:13 ET | 2200 | 6.84 |
11:15 ET | 6281 | 6.8 |
11:18 ET | 3554 | 6.81 |
11:20 ET | 400 | 6.83 |
11:22 ET | 100 | 6.82 |
11:24 ET | 107 | 6.82 |
11:26 ET | 11844 | 6.85 |
11:27 ET | 1200 | 6.91 |
11:29 ET | 231 | 6.93 |
11:31 ET | 736 | 6.88 |
11:33 ET | 330 | 6.87 |
11:36 ET | 281 | 6.895 |
11:38 ET | 300 | 6.86 |
11:42 ET | 100 | 6.85 |
11:44 ET | 100 | 6.88 |
11:49 ET | 201 | 6.895 |
11:51 ET | 100 | 6.885 |
11:56 ET | 100 | 6.92 |
12:00 ET | 660 | 6.95 |
12:02 ET | 8811 | 6.81 |
12:03 ET | 300 | 6.8 |
12:05 ET | 323 | 6.815 |
12:07 ET | 2800 | 6.81 |
12:14 ET | 363 | 6.79 |
12:18 ET | 100 | 6.76 |
12:23 ET | 400 | 6.78 |
12:25 ET | 2344 | 6.76 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Adverum Biotechnologies Inc | 142.4M | -0.7x | --- |
Quantum-Si Inc | 148.9M | -1.5x | --- |
CervoMed Inc | 141.3M | 8.0x | --- |
Galectin Therapeutics Inc | 140.5M | -3.1x | --- |
Acumen Pharmaceuticals Inc | 145.4M | -2.3x | --- |
Cytodyn Inc | 138.1M | -2.5x | --- |
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company. The Company discovers and develops gene therapy product candidates that provides durable efficacy by inducing sustained expression of a therapeutic protein. Its lead product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable levels of aflibercept associated with a sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) IVT injections. Ixo-vec is being developed for the treatment of patients with wet age-related macular degeneration. Its second product candidate, ADVM-062 (AAV.7m8-L-opsin), is a gene therapy product candidate being developed to treat patients suffering from blue cone monochromacy (BCM) via a single IVT injection. It also developing an early-stage pipeline of gene therapy programs.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $142.4M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 20.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.06 |
EPS | $-10.23 |
Book Value | $8.23 |
P/E Ratio | -0.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.